Trial Profile
Cabazitaxel after docetaxel in patients with metastatic, castration-resistant, prostate cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Jul 2015
Price :
$35
*
At a glance
- Drugs Cabazitaxel (Primary) ; Prednisone
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 03 Jul 2015 New trial record
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.